ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,228Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 11

$716K Total Retail Price of All Prescriptions

Rank: 5 out of 11

298 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

34% of this provider’s 298 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 9,031 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 34.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 633 369 S3 1 1
OMEPRAZOLE 469 285 2 3
GABAPENTIN 451 210 3 8
METFORMIN HCL 422 269 4 17
LEVOTHYROXINE SODIUM 420 304 5 2
SIMVASTATIN 404 292 6 9
ATORVASTATIN CALCIUM 295 153 7 13
LISINOPRIL 282 160 8 4
RANITIDINE HCL 282 137 8 27
POTASSIUM CHLORIDE 275 193 10 10
ATENOLOL 266 157 11 29
METOPROLOL TARTRATE 249 215 12 7
FUROSEMIDE 230 172 13 5
FENOFIBRATE 205 121 14 54
LOSARTAN POTASSIUM 200 165 15 21
AMLODIPINE BESYLATE 199 171 16 6
GLIPIZIDE 195 115 17 51
LOVASTATIN 191 153 18 110
HYDROCHLOROTHIAZIDE 190 154 19 32
FLUTICASONE PROPIONATE 186 116 20 38
NEXIUM 158 84 21 31
WARFARIN SODIUM 143 123 22 11
TIZANIDINE HCL 137 55 23 101
COMBIVENT 135 86 24 106
PROAIR HFA 133 68 25 83
TRAZODONE HCL 131 97 26 38
PROMETHAZINE HCL 131 59 R 26 57
NIASPAN 124 50 28 115
SERTRALINE HCL 119 75 29 20
METOPROLOL SUCCINATE 116 79 30 25
CYCLOBENZAPRINE HCL 110 33 R 31 67
JANUVIA 106 65 32 84
TRAMADOL HCL 104 65 33 35
GLIPIZIDE ER 104 72 33 128
SPIRIVA 104 57 33 65
ZETIA 102 41 36 85
CLONIDINE HCL 101 49 37 46
CLOPIDOGREL 98 92 38 30
CRESTOR 91 49 39 27
POLYETHYLENE GLYCOL 3350 89 79 40 14
DIOVAN 87 86 41 49
VENTOLIN HFA 87 57 41 130
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 52 43 75
ACETAMINOPHEN-CODEINE 84 41 S3 44 172
HYDROXYZINE PAMOATE 84 34 R 44 94
PRAVASTATIN SODIUM 82 59 46 19
AMITRIPTYLINE HCL 82 41 R 46 76
VERAPAMIL ER 77 55 48 176
CITALOPRAM HBR 75 40 49 15
PLAVIX 74 69 50 42
CARVEDILOL 73 40 51 16
TRICOR 73 31 51 89
QVAR 71 48 53 184
MIRTAZAPINE 68 63 54 22
BUSPIRONE HCL 68 28 54 56
LANTUS 66 34 56 34
LOSARTAN-HYDROCHLOROTHIAZIDE 64 31 57 88
CELEBREX 63 35 58 93
LIPITOR 62 44 59 81
PREDNISONE 62 41 59 68
ISOSORBIDE MONONITRATE ER 61 42 61 33
LYRICA 60 42 62 74
ADVAIR DISKUS 60 37 62 73
PAROXETINE HCL 60 54 62 78
DONEPEZIL HCL 58 58 65 12
NAPROXEN 58 13 65 112
GLIPIZIDE XL 57 31 67 154
TAMSULOSIN HCL 57 45 67 55
AZITHROMYCIN 55 38 69 62
HYDRALAZINE HCL 53 41 70 45
ALLOPURINOL 52 36 71 41
TRILIPIX 51 32 72 96
ALENDRONATE SODIUM 51 45 72 71
CYMBALTA 50 0 74 40
TOPIRAMATE 50 0 74 126
MELOXICAM 50 12 74 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 19, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.